Narrow complex tachycardia is a fast heart rhythm, over 100 beats per minute, where the electrical signal still travels through the heart’s normal conduction pathways. On an ECG, this shows up as a QRS complex (the spike representing each heartbeat) that’s less than 120 milliseconds wide. That narrow width is the key detail: it tells clinicians the ventricles, your heart’s main pumping chambers, are being activated the way they should be, even though the overall rate is too fast.
The term is an umbrella category, not a single diagnosis. Several different heart rhythms fall under it, each with a different cause and treatment approach.
Why the QRS Stays Narrow
Your heart’s electrical system works like a relay. An impulse starts in the sinoatrial node (your natural pacemaker), travels to the atrioventricular node (a gateway between the upper and lower chambers), then shoots down the bundle of His, a specialized highway of fibers that splits into left and right branches. These branches deliver the signal to both ventricles almost simultaneously, producing a tight, coordinated contraction.
When the signal follows this route, the QRS complex on an ECG looks narrow because both ventricles activate together in a fraction of a second. In narrow complex tachycardia, the problem causing the fast rate typically originates at or above the AV node, not in the ventricles themselves. The ventricles still receive the signal through the normal pathway, so the QRS stays under 120 milliseconds even while the heart races. This is what distinguishes it from wide complex tachycardia, where the signal takes a slower, abnormal route through the ventricle muscle itself.
Types of Narrow Complex Tachycardia
Doctors split these rhythms into two groups based on whether the heartbeat pattern is regular or irregular, because that distinction narrows the possible causes quickly.
Regular Rhythms
Sinus tachycardia is the most common and usually the least concerning. Your heart’s natural pacemaker simply fires faster than normal, often in response to exercise, fever, dehydration, anxiety, or pain. The rhythm looks normal on an ECG, just sped up, with a visible P wave (representing the upper chambers contracting) before every QRS complex. Treatment targets whatever is driving the fast rate rather than the rhythm itself.
AV nodal reentrant tachycardia (AVNRT) is the most common type of SVT (supraventricular tachycardia) that isn’t sinus tachycardia. It happens when the AV node contains two electrical pathways instead of one. An impulse can loop between these pathways, creating a self-sustaining circuit that fires at rates often exceeding 160 beats per minute. Because the signal circles so tightly within the AV node, the P waves are usually buried inside the QRS complex and invisible on the ECG.
AV reentrant tachycardia (AVRT) involves an accessory pathway, an extra bundle of muscle tissue connecting the upper and lower chambers that bypasses the AV node. The electrical signal loops down through the normal pathway and back up through the accessory pathway (or vice versa), creating a racing circuit. If a patient’s baseline ECG shows a telltale pattern called ventricular preexcitation, AVRT is the likely culprit. Wolff-Parkinson-White syndrome is the best-known condition associated with these accessory pathways.
Atrial flutter produces a very fast, organized electrical circuit in the upper chambers, typically firing between 250 and 350 times per minute. The AV node can’t conduct every one of those impulses, so it usually lets through every second or third one, making the actual heart rate more like 125 to 175. On an ECG, atrial flutter creates a characteristic sawtooth pattern between QRS complexes, most visible in the lower leads.
Irregular Rhythms
Atrial fibrillation is the most common irregular narrow complex tachycardia. The upper chambers fire chaotically at rates above 350 per minute, and the ventricles respond at varying intervals, producing an irregularly irregular pulse. The ECG shows no organized P waves, just a wavy, fibrillatory baseline.
Multifocal atrial tachycardia (MAT) occurs when multiple spots in the upper chambers fire independently. It’s most often seen in people with severe lung disease or critical illness. The ECG shows at least three different P wave shapes, reflecting those multiple firing sites.
How It Feels
Sinus tachycardia usually feels like your heart is simply beating hard and fast, and it speeds up and slows down gradually. The reentrant types, AVNRT and AVRT, tend to start and stop abruptly. People often describe a sudden flip or flutter in the chest, followed by a rapid pounding that may last minutes to hours before stopping just as suddenly.
At rates above 150, the heart doesn’t have enough time to fill between beats, so it pumps less blood per contraction. This can cause lightheadedness, shortness of breath, chest pressure, or a feeling of faintness. Most episodes in otherwise healthy people are uncomfortable but not dangerous. Signs that an episode is more serious include true fainting, severe chest pain, difficulty breathing, or confusion, all of which indicate the heart isn’t keeping up with the body’s demands.
How Doctors Tell the Rhythms Apart
An ECG during the episode is the single most useful tool. Clinicians look at three things: whether the rhythm is regular or irregular, the heart rate, and where the P waves are relative to the QRS complexes.
If P waves appear after the QRS (a short interval between the QRS and the following P wave), AVNRT or AVRT is likely. If P waves appear well before the QRS with a normal-looking shape, sinus tachycardia is the usual answer. Inverted or abnormally shaped P waves point toward atrial tachycardia, where the impulse originates from an unusual spot in the upper chambers. No visible P waves at all with an irregular rhythm strongly suggests atrial fibrillation.
When the diagnosis isn’t clear from the surface ECG, an electrophysiology study, where thin catheters are threaded into the heart to map its electrical activity, can pinpoint the exact mechanism.
Stopping an Episode
For reentrant rhythms like AVNRT and AVRT, the first step is often a vagal maneuver, a physical technique that stimulates the vagus nerve and briefly slows conduction through the AV node. The goal is to interrupt the reentrant loop. The most effective version is the modified Valsalva maneuver: you blow hard against resistance (like straining) for 15 seconds while sitting semi-upright, then immediately lie flat with your legs raised. A meta-analysis found this modified technique converts the rhythm back to normal about 43% of the time, compared to only 17% with the standard Valsalva. It’s worth trying before any medication.
If vagal maneuvers don’t work, adenosine is the standard next step for stable patients with a regular narrow complex tachycardia. It’s given as a rapid push into a vein and briefly blocks conduction through the AV node, which either breaks the reentrant circuit or unmasks the underlying rhythm (revealing flutter waves or fibrillatory activity that were hidden). The effect lasts only a few seconds, so the pause is brief even if the rhythm doesn’t convert.
For someone who is hemodynamically unstable, meaning they have dangerously low blood pressure, altered consciousness, severe chest pain, or signs of shock, synchronized cardioversion (a controlled electrical shock timed to the heartbeat) is the immediate treatment regardless of which specific rhythm is causing the problem.
Long-Term Management
The approach depends entirely on which rhythm is responsible and how often episodes occur.
For AVNRT and AVRT, catheter ablation is now offered as a first-line option rather than just a backup after medications fail. The procedure destroys the extra pathway or the slow pathway in the AV node that sustains the reentrant circuit. European Society of Cardiology guidelines recommend discussing ablation upfront with patients, given its high success rate and the possibility of a permanent cure.
For people who prefer medication or aren’t candidates for ablation, heart-rate-slowing drugs like calcium channel blockers or beta-blockers can reduce the frequency and severity of episodes. These were recently downgraded from a top-tier recommendation to a second-tier option for AVNRT, reflecting the growing preference for ablation.
Atrial fibrillation and atrial flutter have their own management pathways that include rate control, rhythm control, and stroke prevention, which go well beyond the narrow complex tachycardia umbrella.
For inappropriate sinus tachycardia, where the heart rate is persistently elevated without an obvious trigger, a newer approach uses ivabradine, a drug that specifically slows the heart’s pacemaker cells, either alone or combined with a beta-blocker. Notably, calcium channel blockers and ablation are no longer recommended for this condition.
Special Considerations
One important exception to the standard treatment approach involves patients with Wolff-Parkinson-White syndrome who develop atrial fibrillation. In this scenario, the chaotic atrial impulses can travel down the accessory pathway directly into the ventricles, bypassing the AV node’s protective filtering. Drugs that slow the AV node, including beta-blockers, calcium channel blockers, and digoxin, are potentially harmful here because they can paradoxically increase conduction through the accessory pathway and trigger a life-threatening ventricular rhythm. Synchronized cardioversion is the recommended treatment for unstable patients in this situation.